Werewolf Therapeutics (HOWL) Short Interest Ratio & Short Volume $1.84 -0.05 (-2.65%) (As of 10/9/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Werewolf Therapeutics Short Interest DataWerewolf Therapeutics (HOWL) has a short interest of 1.12 million shares, representing 3.68% of the float (the number of shares available for trading by the public). This marks a 3.70% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.8, indicating that it would take 3.8 days of the average trading volume of 245,659 shares to cover all short positions.Current Short Interest1,120,000 sharesPrevious Short Interest1,080,000 sharesChange Vs. Previous Month+3.70%Dollar Volume Sold Short$2.62 millionShort Interest Ratio3.8 Days to CoverLast Record DateSeptember 15, 2024Outstanding Shares43,455,000 sharesFloat Size30,400,000 sharesShort Percent of Float3.68%Today's Trading Volume76,614 sharesAverage Trading Volume245,659 sharesToday's Volume Vs. Average31% Short Selling Werewolf Therapeutics? Sign up to receive the latest short interest report for Werewolf Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHOWL Short Interest Over TimeHOWL Days to Cover Over TimeHOWL Percentage of Float Shorted Over Time Ad StockEarningsThese 5 stocks could soar after November 4thEarnings Season: Your FREE Ticket to Trading Success Don't just survive earnings season - learn how to potentially thrive. Discover how to time your trades for maximum potential profit. Bonus: Daily earnings updates delivered straight to your inbox.Click here now to claim your free guide before this offer expires! Werewolf Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/20241,120,000 shares $2.62 million +3.7%3.7%3.8 $2.34 8/31/20241,080,000 shares $2.33 million +1.9%3.6%3.5 $2.16 8/15/20241,060,000 shares $2.14 million +3.9%3.5%3.3 $2.02 7/31/20241,020,000 shares $2.30 million -2.9%3.4%3.2 $2.25 7/15/20241,050,000 shares $3.00 million +55.1%3.5%3.4 $2.86 6/30/2024677,100 shares $1.65 million +38.8%2.3%2.2 $2.44 Get the Latest News and Ratings for HOWL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Werewolf Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 6/15/2024487,900 shares $1.47 million +4.0%1.6%2.3 $3.01 5/31/2024469,100 shares $2.43 million +26.1%1.6%2.5 $5.17 5/15/2024372,000 shares $1.80 million -10.3%1.3%2 $4.85 4/30/2024414,500 shares $2.59 million +1.1%1.4%2.2 $6.24 4/15/2024410,100 shares $2.25 million -13.1%1.4%1.7 $5.49 3/31/2024472,000 shares $3.06 million +9.3%1.6%2 $6.48 3/15/2024432,000 shares $2.65 million -7.1%1.6%1.7 $6.14 2/29/2024464,800 shares $3.22 million +5.0%1.7%1.7 $6.92 2/15/2024442,600 shares $2.79 million +101.9%2.0%1.7 $6.30 1/31/2024219,200 shares $1.01 million -11.8%1.0%0.8 $4.63 1/15/2024248,600 shares $1.25 million -13.2%1.1%0.3 $5.04 12/31/2023286,500 shares $1.11 million -4.6%N/A0.3 $3.86 12/15/2023300,200 shares $897,598.00 -27.0%1.3%0.3 $2.99 11/30/2023411,400 shares $1.01 million -20.7%1.8%0.5 $2.45 11/15/2023518,500 shares $1.14 million +62.9%2.3%0.6 $2.20 10/31/2023318,400 shares $796,000.00 +562.0%1.4%0.4 $2.50 10/15/202348,100 shares $111,111.00 +14.3%0.2%1.5 $2.31 9/30/202342,100 shares $90,094.00 +10.8%0.2%1.2 $2.14 9/15/202338,000 shares $97,660.00 -5.0%0.2%1 $2.57 8/31/202340,000 shares $109,600.00 -36.1%0.2%1 $2.74 8/15/202362,600 shares $157,126.00 +37.6%0.3%1.4 $2.51 7/31/202345,500 shares $122,395.00 -18.3%0.2%1.1 $2.69 7/15/202355,700 shares $176,012.00 -10.0%0.3%1.4 $3.16 6/30/202361,900 shares $188,795.00 +36.6%0.3%1.6 $3.05 6/15/202345,300 shares $150,849.00 -22.4%0.2%1.1 $3.33 5/31/202358,400 shares $186,296.00 +14.5%0.3%1.4 $3.19 5/15/202351,000 shares $143,310.00 No Change0.2%1 $2.81 10/31/2022153,500 shares $454,360.00 -1.7%1.0%1.6 $2.96 10/15/2022156,200 shares $657,602.00 -15.5%1.0%1.8 $4.21 9/30/2022184,900 shares $833,899.00 +42.7%N/A2.7 $4.51 9/15/2022129,600 shares $789,264.00 -10.3%0.9%0.9 $6.09 8/31/2022144,500 shares $731,170.00 -23.9%1.0%1 $5.06 8/15/2022189,800 shares $1.09 million -28.5%1.4%1.3 $5.74 7/31/2022265,300 shares $1.21 million -15.1%2.0%1.8 $4.56Bigger Than Nvidia? (Ad)Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that's all they'll talk about.Go here now for this breaking story. 7/15/2022312,500 shares $1.47 million -37.7%2.4%1.8 $4.70 6/30/2022501,600 shares $2.05 million -50.8%3.8%1.3 $4.09 6/15/20221,020,000 shares $4.73 million +2.4%7.8%2.6 $4.64 5/31/2022996,100 shares $3.78 million +7.4%7.6%3 $3.79 5/15/2022927,900 shares $4.40 million +1.7%7.1%2.8 $4.74 4/30/2022912,000 shares $4.06 million +19.3%7.0%2.9 $4.45 4/15/2022764,400 shares $3.51 million +76.5%5.8%2.6 $4.59 3/31/2022433,000 shares $1.91 million +6.6%N/A1.5 $4.40 3/15/2022406,200 shares $1.86 million +19.6%3.1%5.5 $4.59 2/28/2022339,600 shares $2.43 million +15.3%2.6%2.8 $7.16 2/15/2022294,500 shares $2.21 million +3.6%2.3%2.4 $7.49 1/31/2022284,200 shares $2.59 million -60.8%2.2%2.3 $9.11 1/15/2022725,100 shares $6.47 million -7.2%N/A0 $8.92 12/31/2021781,700 shares $9.31 million +23.0%6.0%7.4 $11.91 12/15/2021635,300 shares $8.85 million -2.6%4.9%6.6 $13.93 11/30/2021651,900 shares $9.45 million -1.0%N/A14.4 $14.49 11/15/2021658,300 shares $10.52 million -3.2%5.0%26.3 $15.98 10/29/2021680,100 shares $10.66 million +0.0%4.4%32.4 $15.67 10/15/2021680,000 shares $11.61 million +2.5%4.4%34 $17.07 9/30/2021663,300 shares $11.38 million -2.0%4.3%25.5 $17.16 9/15/2021676,600 shares $11.71 million +3.9%4.6%11.3 $17.30 8/31/2021651,400 shares $11.59 million -0.8%4.4%8.7 $17.80 8/13/2021656,400 shares $9.48 million No Change4.4%7 $14.44 HOWL Short Interest - Frequently Asked Questions What is Werewolf Therapeutics' current short interest? Short interest is the volume of Werewolf Therapeutics shares that have been sold short but have not yet been closed out or covered. As of September 15th, traders have sold 1,120,000 shares of HOWL short. 3.68% of Werewolf Therapeutics' shares are currently sold short. Learn More on Werewolf Therapeutics' current short interest. What is a good short interest ratio for Werewolf Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HOWL shares currently have a short interest ratio of 4.0. Learn More on Werewolf Therapeutics's short interest ratio. What is a good short interest percentage for Werewolf Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.68% of Werewolf Therapeutics' floating shares are currently sold short. Is Werewolf Therapeutics' short interest increasing or decreasing? Werewolf Therapeutics saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 1,120,000 shares, an increase of 3.7% from the previous total of 1,080,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Werewolf Therapeutics' float size? Werewolf Therapeutics currently has issued a total of 43,455,000 shares. Some of Werewolf Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Werewolf Therapeutics currently has a public float of 30,400,000 shares. How does Werewolf Therapeutics' short interest compare to its competitors? 3.68% of Werewolf Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Werewolf Therapeutics: Rani Therapeutics Holdings, Inc. (5.32%), Shattuck Labs, Inc. (13.29%), Adicet Bio, Inc. (5.07%), Passage Bio, Inc. (3.65%), Xilio Therapeutics, Inc. (0.06%), Curis, Inc. (2.40%), Biora Therapeutics, Inc. (6.36%), Pyxis Oncology, Inc. (8.07%), Nektar Therapeutics (4.36%), GH Research PLC (4.96%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($6.15 billion), Charter Communications, Inc. ($4.04 billion), Paychex, Inc. ($2.77 billion), Nu Holdings Ltd. ($2.71 billion), Cencora, Inc. ($2.34 billion), Aptiv PLC ($2.18 billion), Tractor Supply ($2.07 billion), International Paper ($2.01 billion), AppLovin Co. ($1.95 billion), and Moderna, Inc. ($1.89 billion). View all of the most shorted stocks. What does it mean to sell short Werewolf Therapeutics stock? Short selling HOWL is an investing strategy that aims to generate trading profit from Werewolf Therapeutics as its price is falling. HOWL shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Werewolf Therapeutics? A short squeeze for Werewolf Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HOWL, which in turn drives the price of the stock up even further. How often is Werewolf Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HOWL, twice per month. The most recent reporting period available is September, 15 2024. More Short Interest Resources from MarketBeat Related Companies: RANI Short Squeeze STTK Short Squeeze ACET Short Squeeze PASG Short Squeeze XLO Short Squeeze CRIS Short Squeeze BIOR Short Squeeze PYXS Short Squeeze NKTR Short Squeeze GHRS Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HOWL) was last updated on 10/9/2024 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBigger Than Nvidia?Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the n...InvestorPlace | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredAI Expert Reveals New PickYour Financial Planner Won't Tell You About This Investment Strategy Silicon Valley insider Jeff Brown has ...Brownstone Research | SponsoredClaim Your FREE "AI Income Playbook" Now!Income expert Marc Lichtenfeld has a special gift reserved just for you... It's his brand-new "AI Income Pl...The Oxford Club | SponsoredThis unknown company solves the biggest issue with AINvidia is the 800-lb gorilla in AI chips. But… it has a big problem. That's where one tiny company comes in...Manward Press | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Werewolf Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Werewolf Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.